Coffee, caffeine and blood pressure: A critical review

European Journal of Clinical Nutrition

Volumn 53, Issue 11, 1999, Pages 831-839

  Nurminen, M L ^b   Niittynen, L ^a   Korpela, R ^a   Vapaatalo, H ^c  

^a VALIO LTD   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NONE

Author keywords

Adenosine receptors; Blood pressure; Caffeine; Coffee; Hypertension; Phosphodiesterases

Indexed keywords

ADENOSINE RECEPTOR; CAFFEINE; PHOSPHODIESTERASE;

BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; COFFEE; ENZYME INHIBITION; HEMODYNAMICS; HUMAN; HYPERTENSION; PRESSOR RESPONSE; REVIEW;

EID: 0032713548     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600899     Document Type: Review

References (119)

1. Ahn HY, Karaki H & Urakawa N (1988): Inhibitory effects of caffeine on contractions and calcium movements in vascular and intestinal smooth muscle. Br. J. Pharmac. 93, 267-274.
2. Ammon HPT, Bieck PR, Mandalaz D & Verspohl EJ (1983): Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br. J. Clin. Pharmac. 15, 701-706.
3. Astrup A, Toubro S, Cannon S, Hein P, Breum L & Madsen J (1990): Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr. 51, 759-767.
4. Astrup A, Breum L, Toubro S, Hei P & Quaade F (1992): The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obes 16, 269-277.
5. Bak AAA & Grobbee DE (1990): A randomized study on coffee and blood pressure. J. Hum. Hypertens. 4, 259-264.
6. Bak AAA & Grobbee DE (1991): Caffeine, blood pressure, and serum lipids. Am. J. Clin. Nutr. 53, 971-975.
7. Barone JJ & Roberts HR (1996): Caffeine consumption. Food Chem. Toxicol. 34, 119-129.
8. Bender AM, Donnerstein RL, Samson RA, Zhu D & Goldberg SJ (1997): Hemodynamic effects of acute caffeine ingestion in young adults. Am. J. Cardiol. 79, 696-699.
9. Benowitz NL, Jacob P, Mayan H & Denaro C (1995): Sympathomimetic effects of paraxanthine in humans. Clin. Pharmac. Ther. 58, 684-691.
10. Berkowitz BA & Spector S (1971): Effect of caffeine and theophylline on peripheral catecholamines. Eur. J. Pharmac. 13, 193-196.
11. Birkett NJ & Logan AG (1988): Caffeine-containing beverages and the prevalence of hypertension. J. Hypertens. 6(Suppl 4), S620-S622.
12. Brown NJ, Ryder D, Nadeau J (1993): Caffeine attenuates the renal vascular response to angiotensin II infusion. Hypertension 22, 847-852.
13. Burke V, Beilin LJ, German R, Grosskopf S, Ritchie J, Puddey B & Rogers P (1992): Association of lifestyles and personality characteristics with blood pressure and hypertension: a cross-sectional study in the elderly. J. Clin. Epidemiol. 45, 1061-1070.
14. Burr ML, Gallacher JEJ, Butland BK, Bolton CH & Downs LG (1989): Coffee, blood pressure and plasma lipids: a randomized controlled trial. Eur. J. Clin. Nutr. 43, 477-483.
15. Callahan MM, Robertson RS, Branfman AR, McComish MF & Yesair DW (1983): Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine. Drug Metab. Dispos. 11, 211-217.
16. Casiglia E, Paleari CD, Petucco S, Bongiovi S, Colangeli G, Baccilieri MS, Pavan L, Pernice M & Pessina AC (1992): Haemodynamic effects of coffee and purified caffeine in normal volunteers: a placebo-controlled clinical study. J. Hum. Hypertens. 6, 95-99.
17. Chou TM & Benowitz NL (1994): Caffeine and coffee: effects on health and cardiovascular disease. Comp. Biochem. Physiol. 109C, 173-189.
18. Conlay LA, Conant JA, deBros F & Wurtman R (1997): Caffeine alters plasma adenosine levels. Nature 389, 136.
19. Datta U, Noailles, P-AH, Rodriguez M, Kraft M, Zhang Y & Angulo JA (1996): Accumulation of tyrosine hydroxylase messenger RNA molecules in the rat mesencephalon by chronic caffeine treatment. Neurosci. Lett. 220, 77-80.
20. van Dusseldorp M, Smits P, Thien T & Katan MB (1989): Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension 14, 563-569.
21. van Dusseldorp M, Smits P, Lenders JWM, Thien T & Katan MB (1991): Boiled coffee and blood pressure. A 14-week controlled trial. Hypertension 18, 607-613.
22. Eggertsen E, Andreasson Å, Hedner T, Karlberg BE & Hansson L (1993): Effect of coffee on ambulatory blood pressure in patients with treated hypertension. J. Intern. Med. 233, 351-355.
23. 1α, water, creatinine and electrolyte excretion of the rat. Arzneim.-Forsch./Drug Res. 46, 509-512.
24. France C & Ditto B (1992): Cardiovascular responses to the combination of caffeine and mental arithmetic, cold pressor, and static exercise stressors. Psychophysiology 29, 272-282.
25. Fredholm BB (1995): Adenosine, adenosine receptors and the actions of caffeine. Pharmac. Toxicol. 76, 93-101.
26. Fredholm BB & Dunwiddie TV (1988): How does adenosine inhibit transmitter release? Trends Pharmac. Sci. 9, 130-134.
27. Freestone S & Ramsay LE (1982): Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients. Am. J. Med. 73, 348-353.
28. Goldstein IB & Shapiro D (1987): The effects of stress and caffeine on hypertensives. Psychosom. Med. 49, 226-235.
29. Goldstein IB, Shapiro D, Hui KK & Yu JL (1990): Blood pressure response to the 'second cup of coffee'. Psychosom. Med. 52, 337-345.
30. Green PJ & Suls J (1996): The effects of caffeine on ambulatory blood pressure, heart rate, and mood in coffee drinkers. J. Behav. Med. 19, 111-128.
31. Greenland S (1993): A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4, 366-374.
32. Greenstadt L, Yang L & Shapiro D (1988): Caffeine, mental stress, and risk for hypertension: a cross-cultural replication. Psychosom. Med. 50, 15-22.
33. Gyntelberg F, Hein HO, Suadicani P & Sørensen H (1995): Coffee consumption and risk of ischaemic heart disease - a settled issue? J. Intern. Med. 237, 55-61.
34. Haigh RA, Harper GD, Fotherby M, Hurd J, Macdonald IA & Potter JF (1993): Duration of caffeine abstention influences the acute blood pressure responses to caffeine in elderly normotensives. Eur. J. Clin. Pharmac. 44, 549-553.
35. Hakim AA, Ross GW, Gurb JD, Rodriguez BL, Burchfield CM, Sharp DS, Yano K & Abbott RD (1998): Coffee consumption in hypertensive men in older middle-aged and the risk of stroke: the Honolulu heart program. J. Clin. Epidemiol. 51, 487-494.
36. Hatano Y, Mizumoto K, Yoshiyama T, Yamamoto M & Iranami H (1995): Endothelium-dependent and -independent vasodilation of isolated rat aorta induced by caffeine. Am. J. Physiol. 269, H1679 -H1684.
37. Hibino G, Moritani T, Kawada T & Fushiki T (1997): Caffeine enhances modulation of parasympathetic nerve activity in humans: Quantification using power spectral analysis. J. Nutr. 127, 1422-1427.
38. Hofer I & Bättig K (1993): Coffee consumption, blood pressure tonus and reactivity to physical challenge in 338 women. Pharmac. Biochem. Behav. 44, 573-576.
39. Höfer I & Bättig K (1994): Cardiovascular, behavioral, and subjective effects of caffeine under field conditions. Pharmac. Biochem. Behav. 48, 899-908.
40. Izzo JL, Ghosal A, Kwong T, Freeman RB & Jaenike JR (1983): Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am. J. Cardiol. 52, 769-773.
41. James JE (1994): Chronic effects of habitual caffeine consumption on laboratory and ambulatory blood pressure levels. J. Cardiovasc. Risk 1, 159-164.
42. James JE (1997): Is habitual caffeine use a preventable cardiovascular risk factor? Lancet 349, 279-281.
43. Jee SH, HE J, Whelton PK, Suh I & Klag MJ (1999): The effect of chronic coffee drinking on blood pressure - a meta-analysis of controlled trials. Hypertension 33, 647-652.
44. Jeong D-U & Dimsdale JE (1990): The effects of caffeine on blood pressure in the work environment. Am. J. Hypertens. 3, 749-753.
45. Kalsner S (1971): Mechanism of potentiation of contractor responses to catecholamines by methylxanthines in aortic strips. Br. J. Pharmac. 43, 379-388.
46. Kalsner S (1977): A coronary vasoconstrictor substance is present in regular and 'decaffeinated' forms of both percolated and instant coffee. Life Sci. 20, 1689-1696.
47. Karaki H, Ahn HY & Urakawa N (1987): Caffeine-induced contraction in vascular smooth muscle. Arch. Intern. Pharmacodyn. Ther. 285, 60-71.
48. Kawachi I, Colditz GA & Stone CB (1994): Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br. Heart. J. 72, 269-275.
49. Knutti R, Rothweiler H & Schlatter C (1981): Effects of pregnancy on the pharmacokinetics of caffeine. Eur. J. Clin. Pharmac. 21, 121-126.
50. Kramer GL & Wells JN (1979): Effects of phosphodiesterase inhibitors on cyclic nucleotide levels and relaxation of pig coronary arteries. Mol. Pharmac. 16, 813-822.
51. Kuan C-J, Wells JN & Jackson EK (1990): Endogeneous adenosine restrains renin release in conscious rats. Circul. Res. 66, 637-646.
52. Lane JD & Manus DC (1989): Persistent cardiovascular effects with repeated caffeine administration. Psychosom. Med. 51, 373-380.
53. Lane JD & Williams RB (1987): Cardiovascular effects of caffeine and stress in regular coffee drinkers. Psychophysiology 24, 157-164.
54. Lane JD, Adcock RA, Williams RB & Kuhn CM (1990): Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. Psychosom. Med. 52, 320-336.
55. Lane JD, Phillips-Bute B & Pieper C (1998): Caffeine raises blood pressure at work. Psychosom. Med. 60, 327-330.
56. Lang T, Bureau JF, Degoulet P, Salah H & Benattar C (1983a): Blood pressure, coffee, tea and tobacco consumption: an epidemiological study in Algiers. Eur. Heart J. 4, 602-607.
57. Lang T, Degoulet P, Aime F, Fouriaud C, Jacquinet-Salord M-C, Laprugne J, Main J, Oeconomos J, Phalente J & Prades A (1983b): Relation between coffee drinking and blood pressure: analysis of 6,321 subjects in the Paris region. Am. J. Cardiol. 52, 1238-1242.
58. 2a receptor. Nature 388, 674-678.
59. Lewis CA, Caan B, Funkhouser E, Hilner JE, Bragg C, Dyer A, Raczynski JM, Savage PJ, Armstrong MA & Friedman GD (1993): Inconsistent associations of caffeine-containing beverages with blood pressure and with lipoproteins. Am. J. Epidemiol. 138, 502-507.
60. Lovallo WR, Pincomb GA, Sung BH, Passey RB, Sausen KP & Wilson MF (1989): Caffeine may potentiate adrenocortical stress responses in hypertension-prone men. Hypertension 14, 170-176.
61. Lovallo WR, Pincomb GA, Sung BH, Everson SA, Passey RB & Wilson MF (1991): Hypertension risk and caffeine's effect on cardiovascular activity during mental stress in young men. Health Psychol. 10, 236-243.
62. Lovalto WR, al'Absi M, Blick K, Whitsett TL & Wilson MF (1996a): Stress-like adrenocorticotropin responses to caffeine in young healthy men. Pharmac. Biochem. Behav. 55, 365-369.
63. Lovallo WR, al'Absi M, Pincomb GA, Everson SA, Sung BH, Passey RB & Wilson MF (1996b): Caffeine and behavioral stress effects on blood pressure in borderline hypertensive caucasian men. Health Psychol. 15, 11-17.
64. Löwik MRH, Hofman Z, Kok FJ, Wedel M (1991): Nutrition and blood pressure among elderly men and women (Dutch Nutrition Surveillance System). J. Am. Coll. Nutr. 10, 149-155.
65. MacDonald TM, Sharpe K, Fowler G, Lyons D, Freestone S, Lovell HG, Webster J & Petrie JC (1991): Caffeine restriction: effect on mild hypertension. Br. Med. J. 303, 1235-1238.
66. Massey LK (1998): Caffeine and the elderly. Drugs Aging 13, 43-50.
67. Mehta A, Jain AC, Mehla MC & Billie M (1997): Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiol. 52, 273-283.
68. Moriyama K, Osugi S, Shimamura K & Sunano S (1989): Caffeine-induced, contraction in arteries from stroke-prone spontaneously hypertensive rats. Blood Vessels 26, 280-289.
69. Mosqueda-Garcia R, Tseng C-J, Biaggioni I, Robertson RM & Robertson D (1990): Effects of caffeine on baroreflex activity in humans. Clin. Pharmac. Ther. 48, 568-574.
70. Myers HF, Shapiro D, McClure F & Daims F (1989): Impact of caffeine and psychological stress on blood pressure in black and white men. Health Psychol. 8, 597-612.
71. Myers MG & Reeves RA (1991): The effect of caffeine on daytime ambulatory blood pressure. Am. J. Hypertens 4, 427-431.
72. Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzuol F & Palantini P (1995): Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. J. Hyperlens. 13, 965-970.
73. van Nguyen P & Myers MG (1988): Cardiovascular effects of caffeine and nifedipine. Clin. Pharmac. Ther. 44, 315-319.
74. Nussberger J, Mooser V, Maridor G, Juillerat L, Waeber B & Brunner HR (1990): Caffeine-induced diuresis and atrial natriuretic peptides. J. Cardiovasc. Pharmac. 15, 685-691.
75. Ohnishi A, Li P, Branch RA, Holycross B & Jackson EK (1987): Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interactin with the sympathetic nervous system. J. Clin. Invest. 80, 13-16.
76. Olah ME, Stiles GL (1995): Adenosine receptor subtypes: characterization and therapeutic regulation. Ann. Rev. Pharmac. Toxicol. 35, 581-606.
77. Onrot J, Goldberg MR, Biaggioni I, Hollister AS. Kincaid D & Robertson D (1985): Hermodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. New Engl. J. Med. 313, 549-554.
78. Palatini P, Canali C, Graniero GR, Rossi G, de Toni R, Santonastaso M, dal Follo M, Zanata G, Ferrarese E, Mormino P & Pessina AC (1996): Relationship of plasma renin activity with caffeine intake and physical training in mild hypertensive men. Eur. J. Epidemiol. 12, 485-491.
79. Parsons WD & Neims AH (1978): Effect of smoking on caffeine clearance. Clin. Pharmac. Ther. 24, 40-45.
80. Passmore AP, Kondowe GB & Johnston GD (1987): Renal and cardiovascular effects of caffeine: a dose-response study. Clin. Sci. 72, 749-756.
81. Periti M, Salvaggio A, Quaglia G & DiMarzio L (1987): Coffee consumption and blood pressure: an Italian study. Clin. Sci. 72, 443-447.
82. Phillips-Bute BG & Lane JD (1998): Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol. Behav. 63, 35-39.
83. Pincomb GA, Lovallo WR, Passey RB, Whitsett TL, Silverstein SM & Wilson MF (1985): Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men. Am. J. Cardiol. 56, 119-122.
84. Pincomb GA, Lovallo WR, Passey RB & Wilson MF (1988): Effect of behavior state on caffeine's ability to alter blood pressure. Am. J. Cardiol. 61, 798-802.
85. Pincomb GA, Wilson MF, Sung BH, Passey RB & Lovallo WR (1991): Effects of caffeine on pressor regulation during rest and exercise in men at risk for hypertension. Am. Heart J. 122, 1107-1115.
86. Pirich Ch, O'Grady J & Sinzinger H (1993): Coffee, lipoproteins and cardiovascular disease. Wien Klin. Wochenschr. 105, 3-6.
87. Potter JF, Haigh RA, Harper GD, Fortherby M. Hurd S & Macdonald IA (1993): Blood pressure, plasma catecholamine and renin responses to caffeine in elderly hypertensives. J. Hum. Hypertens. 7, 273-278.
88. Rakic V, Burke V & Beilin LJ (1999): Effects of coffee on ambulatory blood pressure in older men and women - a randomized controlled trial. Hypertension 33, 869-873.
89. Ray RL, Nellis MJ, Brady JV & Foltin RW (1986): Nicotine and caffeine effects on the task-elicited blood pressure response. Addict. Behav. 11, 31-36.
90. Robertson D, Frolich JC, Can RK, Watson JT, Hollifield JW, Shand DG & Gates JA (1978): Effects of caffeine on plasma renin activity, catecholamines and blood pressure. New Engl. J. Med. 298, 181-186.
91. Robertson D, Wade D, Workman R, Woosley RL & Oates JA (1981): Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 67, 1111-1117.
92. Robertson D, Hollister AS, Kincaid D, Workman R, Goldberg MR, Tung C-S & Smith B (1984): Caffeine and hypertension. Am. J. Med. 77, 54-60.
93. Rosmarin PC, Applegate WB & Somes GW (1990): Coffee consumption and blood pressure: a randomized, crossover clinical trial. J Gen. Intern. Med. 5, 211-213.
94. Salvaggio A, Periti M, Miano L & Zambelli C (1990): Association between habitual coffee consumption and blood pressure levels. J. Hypertens. 8, 585-590.
95. 2+ levels in vascular smooth muscle of rat aorta. Naunyn-Schmiedeberg's Arch. Pharmac. 338, 443-448,
96. Sharp DS & Benowitz NL (1990): Pharmacoepidemiology of the effect of caffeine on blood pressure. Clin. Pharmac. Ther. 47, 57-60.
97. Shimamura K, Moriyama K & Sunano S (1991): Caffeine-induced contraction of rat portal vein and effects of K-depolarization, Na-removal and low temperature. J. Smooth Muscle Res. 27, 75-85.
98. Shirlow MJ, Berry G & Stokes G (1988): Caffeine consumption and blood pressure: an epidemiological study. Int. J. Epidemiol. 17, 90-97.
99. 1-selective and nonselective β-blockade. Clin. Pharmacol. Ther. 34, 153-158.
100. Smits P, Thien T & van't Laar A (1985): Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am. J. Cardiol 56, 958-963.
101. Smits P, Pieters G & Thien T (1986a): The role of epinephrine in the circulatory effects of coffee. Clin. Pharmac. Ther. 40, 431-437.
102. Smits P, Thien T & van't Laar A (1986b): Influence of slow calcium-channel blockade on the cardiovascular effects of coffee. Eur. J. Clin. Pharmac: 30, 171-175.
103. Smits P, Schouten J & Thien T (1989): Cardiovascular effects of two xanthines and the relation to adenosine antagonism. Clin. Pharmac. Ther. 45, 593-599.
104. Snider SR & Waldeck B (1974): Increased synthesis of adrenomedullary catecholamines induced by caffeine and theophylline. Naunyn-Schmiedeberg's Arch. Pharmac. 281, 257-260.
105. van Soeren M, Mohr T, Kjaer M & Graham TE (1996): Acute effects of caffeine ingestion at rest in humans with impaired epinephrine responses. J. Appl. Physiol. 80, 999-1005.
106. Stensvold I, Tverdal A & Foss OP (1989): The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J. Clin. Epidemiol. 42, 877-884.
107. Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, Mattfeldt-Beman M, Oberman A, Sugars C & Dalcin AT (1993): Weight loss intervention in phase I of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch. Intern. Med. 153, 849-858.
108. Strickland TL, Myers HF & Lahey BB (1989): Cardiovascular reactivity with caffeine and stress in black and white normotensive females. Psychosom. Med. 51, 381-389.
109. Sung BH, Whitsett TL, Lovallo WR, al'Absi M, Pincomb GA & Wilson MF (1994): Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men. Am. J. Hypertens 7, 755-758.
110. Superko HR, Botz W, Williams PT, Albers JJ & Wood PD (1991): Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial. Am. J. Clin. Nutr. 54, 599-605.
111. Superko HR, Hyll J, DiRicco C, Williams PT, Bortz WM & Wood PD (1994): Effects of cessation of caffeinated-coffee consumption on ambulatory and resting blood pressure in men. Am. J. Cardiol. 73, 780-784.
112. Tang-Liu DD-S, Williams RL & Riegelman S (1983): Disposition of caffeine and its metabolites in man. J. Pharmac. Exp. Ther. 224, 180-185.
113. Thelle DS, Heyden S & Fodor JG (1987): Coffee and choleserol in epidemiological and exerimental studies. Atherosclerosis 67, 97-103.
114. Thompson WG (1994): Coffee: brew or bane? Am. J. Med. Sci. 308, 49-57.
115. Tse SYH (1992): Cholinomimetic compound distinct from caffeine contained in coffee. II: muscarinic actions. J. Pharm. Sci. 81, 449-452.
116. Urgert R & Katan MB (1997): The cholesterol-raising factor from coffee beans. Am. Rev. Nutr. 17, 305-324.
117. Wakabayashi K, Kono S, Shinchi K, Honjo S, Todoroki I, Sakurai Y, Umeda T, Imanishi K & Yoshizawa N (1998): Habitual coffee consumption and blood pressure: a study of self-defence officials in Japan. Eur. J. Epidemiol. 14, 669-673.
118. Walker BR & Williams BC (1992): Corticosteroids and vascular tone: mapping the messenger maze. Clin. Sci. 82, 597-605.
119. Wilson PWF, Garrison RJ, Kannel WB, McGee DL & Castelli WP (1989): Is coffee consumption a contributor to cardiovascular disease? Arch. Intern. Med. 149, 1169-1172.